DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Adjusted EPS | ₹82.68 | ₹60.38 | ₹68.83 | ₹111.53 | ₹74.75 |
What is the latest Earnings Per Share (EPS) of DIVIS LABORATORIES ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2025 | ₹82.68 |
Mar2024 | ₹60.38 |
Mar2023 | ₹68.83 |
Mar2022 | ₹111.53 |
Mar2021 | ₹74.75 |
How is Earnings Per Share (EPS) of DIVIS LABORATORIES Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2025 | ₹82.68 | 36.93 | |
Mar2024 | ₹60.38 | -12.28 | |
Mar2023 | ₹68.83 | -38.29 | |
Mar2022 | ₹111.53 | 49.20 | |
Mar2021 | ₹74.75 | - |
Compare Earnings Per Share (EPS) of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹172,393.1 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
MANKIND PHARMA | ₹108,482.0 Cr | 3% | 7.8% | 27.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.8% |
-5.9% |
29.2% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses